Agilent Expands Presence in Colorado
Agilent Technologies has acquired 20 acres of land in Weld County, Colorado, USA, on which to build a pharmaceutical manufacturing facility.
Agilent Technologies (Santa Clara, California, USA) has acquired 20 acres of land in Weld County, Colorado, USA, on which to build a pharmaceutical manufacturing facility.
The expansion will enable the company to more than double its commercial manufacturing capacity for nucleic acid active pharmaceutical ingredients.
“The products manufactured at this site will be used by our customers to improve the lives of patients suffering from a variety of diseases,” said Skip Thune, general manager of the company’s Nucleic Acids Solutions Division. “At Agilent, we are committed to meeting the everâincreasing needs of our customers for oligonucleotides.”
Thune also noted that the expansion would result in about 150 to 200 new jobs.
“Colorado is thrilled to welcome Agilent Technologies to the state,” said Governor John Hickenlooper. “This expansion will enhance Colorado’s skilled workforce and dedication to research and development firms. We look forward to supporting Agilent’s innovative work in our state.”
For more information please visit: www.agilent.com
LC–MS/MS-Based System Used to Profile Ceramide Reactions to Diseases
April 26th 2024Scientists from the University of Córdoba in Córdoba, Spain recently used liquid chromatography–tandem mass spectrometry (LC–MS/MS) to comprehensively profile human ceramides to determine their reactions to diseases.
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.
